David Younger
David Younger is the Co-Founder and CEO of A-Alpha Bio, a Seattle-based biotechnology company applying synthetic biology and machine learning to engineer and predict protein-protein interactions. He is a co-inventor of the AlphaSeq platform, which enables quantitative measurements used in therapeutic antibody and molecular glue discovery. He previously worked as a postdoctoral researcher at the University of Washington.
A-Alpha Bio, led by CEO David Younger, launches AI antibody data consortium with GSK and Boltz among five founders
A-Alpha Bio, a company spun out of David Baker's work and led by CEO David Younger, has launched a first-of-its-kind AI antibody data consortium with five founding members including GSK and Boltz to supply data for AI models designing antibodies.
BioBead Wins $25,000 BECU Grand Prize as Dempsey Startup Awards Distribute Record $92,500 to Student Ventures
The 29th Dempsey Startup Awards awarded a record $92,500 to student entrepreneurs across the Cascadia region, with University of Washington’s BioBead winning the $25,000 BECU Grand Prize for a biodegradable soil probiotic aimed at restoring soil health and improving crop yields.
Trump-Era Funding Cuts and Hiring Freeze Stall UW Protein Design Startups Led by Nobel Laureate David Baker
The University of Washington's Institute for Protein Design, led by Nobel laureate David Baker, faces a hiring freeze and funding cuts under the Trump administration, stalling its promising protein design startups and reducing opportunities for graduate students and postdocs. Despite Nobel-driven interest and advances in AI-designed proteins, budget constraints threaten future innovation and company spinoffs.
See all 15 stories, episodes and videos about David Younger.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
See all 4-
A-Alpha Bio Executive Officer, Director 2019–present, Chief Executive Officer & Co-Founder 2017–present · current
-
University of Washington Postdoctoral Researcher 2017–2018, Bioengineering Graduate Student 2012–2017 · past
-
Luminex Corporation Engineering Intern 2011 · past
Education
-
University of Washington Doctor of Philosophy (PhD), Bioengineering · 2012–2017
-
Rice University Bachelor of Science; Bachelor of Arts, Bioengineering, Economics · 2007–2012
-
The London School of Economics and Political Science (LSE) Economics · 2009–2010